RxDoctor Payments Data

Roman Nation, MD

Family Medicine · Panama City, FLNPI 1710070438

Payments from drug & device makers

$58,720in general payments, 2019–2025

Across 355 payments — averaging $165.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Dendreon Pharmaceuticals LLC$48K
  • CGG Medical Inc$6K
  • AbbVie$788
  • Pfizer$546
  • Novo Nordisk$527
  • AstraZeneca$337
  • plus $3K from 29 others

What the payments were for

  • Consulting fees$48,00082%
  • Speaking & faculty fees$6,00010%
  • Food & beverage$4,7068%
  • Education$140%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$58,720 in reported general payments places this provider in the 95th percentile of 7,282 family medicine providers in Florida.

See all family medicine providers in Florida

Medicare billing

Part B allowed, 2024
$419,954
Medicare patients
619
Services billed
9,630

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide31$48,169
EliquisApixaban52$43,143
JardianceEmpagliflozin19$18,293
EntrestoSacubitril/Valsartan12$8,949
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen256$5,275
Testosterone Cypionate27$2,328
Liothyronine Sodium46$2,175
Morphine Sulfate ErMorphine Sulfate43$1,679
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen44$1,211
Levothyroxine Sodium123$1,147
Atorvastatin Calcium123$1,131
Omega-3 Acid Ethyl Esters21$1,091
Lantus SolostarInsulin Glargine,hum.Rec.Anlog12$988
Albuterol Sulfate HfaAlbuterol Sulfate29$986
Omeprazole80$920

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$527$48,16931 claims
PfizerEliquis$546$43,14352 claims
Boehringer IngelheimJardiance$127$18,29319 claims
NovartisEntresto$116$8,94912 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 7,282 family medicine providers in Florida.

Other family medicine in Panama City

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →